Mingjie Wei | Biochemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. Mingjie Wei | Biochemistry | Best Researcher Award

Doctor at Hubei University of Science and Technology, China

Dr. Mingjie Wei is a dedicated researcher and innovator in the fields of fluorescence sensors, bioimaging, organocatalysis, and drug design. With a solid foundation in chemistry and years of progressive experience across academic and industrial research settings, Dr. Wei has made meaningful contributions to chemical sciences. His research efforts are underscored by high-impact publications, patents, and leadership roles, positioning him as a promising figure in modern chemical innovation and translational science.

profile

scopus

Education

Dr. Wei began his academic journey in chemistry at Hainan University, where he earned his bachelor’s degree in 2010 under the supervision of Prof. Shiming Deng. He then pursued a master’s degree at Hunan Normal University, graduating in 2013, under the mentorship of Prof. Youyu Zhang and as part of Academician Yao Shouzhuo’s prestigious research team. His doctoral studies were completed at Sun Yat-sen University in 2021, where he worked under Prof. Le Li, focusing on cutting-edge topics in organocatalysis and fluorescence-based detection techniques.

Experience

Dr. Wei’s professional trajectory spans both academia and industry. He is currently a postdoctoral researcher at Guangzhou University under the guidance of Prof. Li Niu (since May 2024). Prior to this, he served as a high-level faculty member and master’s supervisor at Hubei University of Science and Technology from 2022, playing a critical role in teaching and mentoring graduate students. His industrial experience includes serving as R&D Director at Dongguan Biotechnology Development Co., Ltd. (2021–2022) and Project Manager at HEC Pharmaceutical Industry (2013–2016), where he led the development of several innovative drug and sensor technologies. He also contributed as a research assistant at Sun Yat-sen University (2016–2017), building further expertise in analytical chemistry.

Research Interest

Dr. Wei’s research interests are rooted in interdisciplinary chemistry. He focuses on fluorescence sensors and bioimaging, particularly for real-time detection of biological and environmental targets. His work also delves into organocatalysis and rational drug design, combining synthetic chemistry with molecular diagnostics. Through novel probe development and mechanistic studies, he aims to bridge the gap between chemical innovation and biomedical applications. His projects often emphasize sensitivity, selectivity, and biocompatibility—key metrics for translational success.

Award

Dr. Wei has been recognized for his academic and scientific excellence through multiple competitive grants and fellowships. These include the prestigious China Postdoctoral Science Foundation Award (2024M760620), Hubei Science and Technology Program grant (2022CFB781), and a Doctoral Startup Fund Project from Hubei University of Science and Technology. Additionally, he leads a university-level teaching reform project, further demonstrating his commitment to pedagogical excellence alongside research.

Publication

Dr. Wei has authored multiple peer-reviewed articles in high-impact journals. Below are seven select publications, showcasing his diverse research contributions:

Chem. Eng. J. (2025) – Co-authored a study on nanomaterials for environmental detection, cited by 12 articles.

Sci. China Chem. (2025) – Investigated advanced fluorescence probes, cited by 9 articles.

J. Colloid Interface Sci. (2025) – Developed biosensing platforms with clinical relevance, cited by 6 articles.

J. Colloid Interface Sci. (2023) – Explored novel colloidal interactions for sensor enhancement, cited by 18 articles.

Angew. Chem. Int. Ed. (2021) – Contributed to catalyst development for selective transformations, cited by 27 articles.

Spectrochim. Acta A (2024) – Published on spectroscopic methods in analyte detection, cited by 5 articles.

Anal. Methods (2017) – Designed a fluorescence-based method for metal ion detection, cited by 22 articles.

These publications reflect Dr. Wei’s consistent scholarly output and his ability to address diverse challenges in analytical and synthetic chemistry.

Conclusion

Dr. Mingjie Wei exemplifies the qualities of a distinguished researcher — scientific excellence, innovative spirit, and a commitment to translational impact. His robust academic foundation, rich professional experience, and outstanding scholarly output position him as a highly deserving candidate for the Best Researcher Award. Recognizing Dr. Wei would not only honor his individual achievements but also encourage continued innovation in chemical and biomedical sciences.

 

Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Manager at Mitsubishi Corporation Life Sciences Limited, Japan

Dr. Hisae Aoshima is an accomplished researcher in the field of cosmetic science with over two decades of dedicated work in fullerene-related research and its applications in dermatology. She is currently serving as the Manager of the Research and Development Group in the Cosmetic Division at Mitsubishi Corporation Life Sciences Ltd., following the integration of Vitamin C60 BioResearch Corporation into the company in April 2024. Her expertise has significantly contributed to the development of innovative cosmetic ingredients, notably Repista, a novel compound introduced under her leadership. Renowned for her technical acumen and pioneering spirit, Dr. Aoshima has gained international recognition for her research presentations and scientific publications.

profile

scopus

Education

Dr. Aoshima’s academic credentials reflect a deep commitment to interdisciplinary scientific exploration. She earned her second doctoral degree, a Doctor of Agriculture, from Shizuoka University in 2025, focused on the biological and dermatological efficacy of Repista. Prior to this, she received her first doctorate, a Doctor of Engineering, in 2010 from Nagaoka Technical University, where she concentrated on fullerene chemistry. Her graduate studies began with a Master of Science in 1999, following a Bachelor of Science in 1997, both from the same university, establishing her strong foundational knowledge in scientific research and material science.

Experience

With approximately 20 years of professional experience in the cosmetic and chemical research industry, Dr. Aoshima has held key positions contributing to product innovation and research strategy. Her career began in a private contract research firm as a researcher, where she honed her laboratory and project management skills. She then advanced to a managerial role at Vitamin C60 BioResearch Corporation, a company known for its pioneering work with fullerenes. Since the company’s merger into Mitsubishi Corporation Life Sciences Ltd., she has continued to lead R&D efforts, focusing on the cosmetic division. Her role involves supervising research projects, formulating active cosmetic ingredients, and translating complex chemical innovations into market-ready applications.

Research Interest

Dr. Aoshima’s research interests center on fullerene chemistry, dermatological applications of nanomaterials, and the development of bioactive cosmetic ingredients. Her work investigates the antioxidant and anti-inflammatory effects of fullerenes in skin health, as well as their integration into skincare formulations. Her most notable research revolves around Repista, a unique fullerene derivative that offers promising anti-aging and skin-regenerative benefits. She is also passionate about bridging the gap between bioengineering and consumer product science, contributing to the advancement of aesthetic dermatology through safe, science-backed innovations.

Award

Throughout her career, Dr. Aoshima has received multiple accolades for her groundbreaking work. Most notably, she was honored with the Best Presentation Award at the 39th Annual Meeting of the Japanese Society of Aesthetic Dermatology in 2021 for her study on Repista’s skin benefits. This recognition underscored her ability to convey complex scientific findings in a compelling and applicable manner. Additionally, her consistent contributions to cosmetic science have positioned her as a respected voice within various professional societies, where she actively participates in academic and industry dialogues.

Publication

Dr. Aoshima has authored 38 peer-reviewed academic papers, with 13 of them as the first author, showcasing her extensive contribution to scientific literature. Noteworthy among these are:

“Protective Effects of Repista on Skin Aging” (Journal of Cosmetic Dermatology, 2024, cited by 18 articles),

“Antioxidative Behavior of Fullerene Derivatives in Human Skin Cells” (Materials Science in Medicine, 2022, cited by 25 articles),

“Synergistic Effects of Fullerene and Vitamin C in Cosmetic Applications” (International Journal of Cosmetic Science, 2020, cited by 31 articles),

“Fullerene Stability and Delivery Mechanisms in Skin Cream Formulations” (Colloid Interface Science Reports, 2018, cited by 22 articles),

“Fullerene-Enhanced Sunscreen Agents” (Dermatological Science Reviews, 2016, cited by 16 articles),

“Nano-Antioxidants in Anti-Aging Therapies” (Advanced Cosmetic Technology, 2014, cited by 29 articles),

“Evaluation of Fullerene-Infused Serums in Long-Term Skin Application” (Journal of Aesthetic Science, 2012, cited by 20 articles).

Conclusion

With an exceptional blend of academic achievement, innovation-driven research, practical application in cosmetic science, and recognized leadership in fullerene and Repista-based product development, Dr. Hisae Aoshima exemplifies the qualities deserving of the Best Researcher Award. Her deep interdisciplinary knowledge, commitment to advancing cosmetic bioengineering, and recognized industry impact make her a model candidate whose contributions continue to shape the future of dermatological and anti-aging science.

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Posted on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition

Mohammad Doroudian | Nanomedicine | Best Researcher Award

Posted on by Medical Lab Scientist

Dr. Mohammad Doroudian | Nanomedicine | Best Researcher Award

Assistant Professor at Kharazmi Univrsity, Iran

Dr. Mohammad Doroudian is a distinguished molecular and cell biologist with extensive academic and research contributions in nanomedicine, immunology, and biotechnology. He currently serves as an Assistant Professor at Kharazmi University, Tehran, where he also directs international relations within the Faculty of Biological Sciences. With a research portfolio spanning over a decade, Dr. Doroudian has emerged as a leading figure in the integration of nanotechnology into therapeutic innovations for inflammation and cancer.

profile

scopus

Education

Dr. Doroudian earned his Ph.D. in Molecular and Cell Biology from Trinity College Dublin (TCD), University of Dublin (2015–2019), supported by a full scholarship from Science Foundation Ireland. He also held a research studentship at Osaka University’s Faculty of Medicine in Japan (2014). His academic excellence has been recognized since early stages of his career, ranking 1st in Iran’s MSc Entrance Examination (2009) and 4th in the National Ph.D. Entrance Exam (2013).

Experience

Dr. Doroudian has held multiple academic and leadership roles. Since 2019, he has been serving as an Assistant Professor at Kharazmi University. His portfolio includes roles as the Director of International Relations, Internal Manager of the Nova Biologica Reperta journal, and Guest Editor for reputed journals such as Pharmaceutics, Frontiers in Chemistry, and Genes. Earlier in his career, he was a Research Assistant at the Pasteur Institute of Iran and the head of the Molecular Detection Department at ASA Laboratory. Dr. Doroudian has also contributed to scientific events as a symposium secretary and served in editorial capacities.

Research Interests

Dr. Doroudian’s research interests lie at the intersection of cell and molecular biology, nanomedicine, and biotechnology. His work primarily focuses on smart nanotherapeutics for cancer, exosome-based therapies, gene editing, and drug delivery systems. His research applies interdisciplinary methods to address challenges in respiratory and inflammatory diseases, as well as infectious disease modeling.

Awards

He has received numerous accolades, including the Research Excellence Award from Kharazmi University (2024), Young Researcher Prize by Iran’s Vice-Presidency for Science and Technology (2022), and the Top Presentation Award at the 3rd Conference on Novel Achievements in Biology (2023). He is also a recipient of the National Elite Foundation Grants and has been recognized as a premier member of the Young Researchers and Elite Club.

Publications

Dr. Doroudian has published over 80 peer-reviewed papers in international journals, several of which are highly cited. Selected recent publications include:

Doroudian et al. (2024). Identification of meat adulteration in minced meat samples using duplex PCR, Food Science & Nutrition, cited in food authenticity studies.

Doroudian et al. (2023). Nano Based-Oncolytic Viruses for Cancer Therapy, Critical Reviews in Oncology/Hematology, referenced for viral nanotherapy.

Doroudian et al. (2023). Smart Lipid-Based Nanoparticles in Lung Cancer Treatment, Advanced Therapeutics, cited in cancer nanomedicine.

Doroudian et al. (2022). Nanocarriers for CRISPR/Cas Delivery, Frontiers in Chemistry, influential in gene editing strategies.

Doroudian et al. (2021). Aerosolized drug-loaded nanoparticles for respiratory inflammation, Nanomedicine, widely cited in biofilm modulation research.

Doroudian et al. (2020). Exosomal microRNAs in cervical cancer, Epigenomics, recognized for exosomal biomarker innovation.

Doroudian et al. (2018). Identification of Novel Genes in COPD via Machine Learning, Scientific Reports, cited in computational biology.

Conclusion

Dr. Mohammad Doroudian’s distinguished academic background, prolific research output, global collaboration, editorial leadership, and sustained national and international recognition mark him as an outstanding candidate for the Best Researcher Award. His contributions significantly advance the fields of molecular biology and nanomedicine, demonstrating both depth and innovation. His trajectory continues to inspire the next generation of scientists while directly contributing to pressing medical challenges worldwide

Yuewen Zhang | microfluidics | Best Researcher Award

Posted on by Medical Lab Scientist

Prof. Yuewen Zhang | microfluidics | Best Researcher Award

Professor at Lanzhou University, China

Dr. Yuewen Zhang is a professor of Analytical Chemistry at Lanzhou University, China, with a robust interdisciplinary background spanning molecular biology, drug design, and biophysics. He has contributed significantly to the fields of microfluidics, protein analysis, and nanostructure-based detection methods. Dr. Zhang has held research positions in globally respected institutions such as the University of Cambridge and the National Physical Laboratory in the UK, and his scholarly output reflects a commitment to both scientific innovation and impactful societal application. His work in analytical chemistry integrates advanced materials with microfabrication and artificial intelligence, positioning him as a dynamic contributor to chemical sensing, environmental monitoring, and biomedical diagnostics.

profile

scopus

Education

Dr. Zhang holds a Ph.D. in Biophysics from the University of Cambridge, where he worked under the supervision of Prof. Tuomas Knowles. His doctoral research focused on investigating protein properties through microfluidic technologies, a project that laid the foundation for his later contributions to biosensing. Prior to that, he earned his MSc in Drug Design at University College London under the mentorship of Professors John Christodoulou and Edith Chan, where he explored molecular interactions using NMR spectroscopy. Dr. Zhang began his academic journey with a BSc in Molecular Biology, first at Xi’an Jiaotong-Liverpool University and later completed at the University of Liverpool, combining rigorous coursework with early research exposure.

Experience

Currently serving as a professor at Lanzhou University since 2019, Dr. Zhang teaches and leads laboratory work in molecular biology and biochemistry. His prior experience includes working as a Higher Research Scientist at the National Physical Laboratory and as a Postdoctoral Research Associate at the University of Exeter. During these appointments, he furthered his expertise in microfluidics, single-cell analysis, and environmental sensing technologies. At Lanzhou University, he also supervises graduate research and actively contributes to curriculum development in analytical sciences.

Research Interest

Dr. Zhang’s research lies at the interface of chemistry, biology, and engineering. His core focus is the development of microfluidic platforms for biosensing, integrating novel nanomaterials such as plasmonic nanoaggregates and hollow structures for high-sensitivity detection. He is also passionate about leveraging deep learning for pathogen detection and exploring sustainable chemistry solutions such as CO₂ reduction and pollutant purification. His projects aim to bridge fundamental research with real-world applications in environmental safety and human health diagnostics.

Awards and Grants

Dr. Zhang’s research excellence has been acknowledged through numerous grants and accolades. Notably, he has received funding from the National Natural Science Foundation of China and the Natural Science Foundation of Gansu Province. He is also a recipient of the Fundamental Research Funds for the Central Universities and was recognized under the “Double First-Class” Construction Project. Furthermore, his projects have been supported by industry collaborations, including a grant from Zaiyuan Pharmaceutical Company. These awards underscore his ability to drive impactful research across academic and commercial landscapes.

Selected Publications

Among his prolific output, seven key publications stand out:

High-Precision Construction of Colloidal Superstructures through Cucurbit[n]Uril-Mediated Self-Assembly, Macromol. Chem. Phys., 2025, cited by 14 articles.

Hollow Raspberry-Like Nanoaggregates for Sensitive SERS Detection of PAHs in Water, Chem. Eng. J., 2025, cited by 18 articles.

Engineering Single Ni Sites on 3D Cage‐like Cucurbit[n]uril Ligands for CO₂ Photocatalytic Reduction, Angew. Chem., 2025, cited by 22 articles.

Encapsulation of Hollow Polystyrene Particles in PDMS Membranes for Natural Gas Purification, J. Environ. Chem. Eng., 2025, cited by 9 articles.

Development of a Cost-Effective Confocal Raman Microscopy with High Sensitivity, Talanta, 2025, cited by 11 articles.

Deep Learning-Enhanced Microfluidic Biosensing for Pathogen Detection, Sens. Actuators B Chem., 2025, cited by 15 articles.

Raspberry-Like Plasmonic Nanoaggregates for SERS Detection of Pollutants and Biomarkers, Anal. Chem., 2024, cited by 20 articles.

Conclusion

Given Dr. Yuewen Zhang’s exceptional record in research productivity, innovative scientific contributions, successful grant acquisition, commitment to education, and international collaboration, he stands out as a highly qualified and deserving nominee for the Best Researcher Award. His interdisciplinary expertise and dedication to addressing real-world challenges through science make him not only a leader in his field but also a valuable asset to the global research community.

Hossein Salehi | Human Anatomy & Physiology | Excellence in Medical Research Award

Posted on by Medical Lab Scientist

Dr. Hossein Salehi | Human Anatomy & Physiology | Excellence in Medical Research Award

Academic professor at Isfahan university of medical sciences, Iran

Professor Hossein Salehi Rozveh is a distinguished academic in anatomical sciences, currently serving as the Head of the Department of Anatomical Sciences at the School of Medicine, Isfahan University of Medical Sciences. With a comprehensive career spanning over two decades in both research and education, he has established himself as a pioneer in histology, embryology, and stem cell biology. His scientific dedication, interdisciplinary approach, and contribution to regenerative medicine and neural tissue engineering make him a compelling candidate for this award. He has held various positions from lecturer to full professor, consistently demonstrating academic leadership and mentorship across disciplines.

profile

scopus

Education

Professor Salehi’s academic foundation is deeply rooted in medical and biological sciences. He earned his B.Sc. in Nursing from Isfahan University of Medical Sciences (1996–2000), followed by an M.Sc. in Histology and Embryology from Kermanshah University of Medical Sciences (2000–2003), where he ranked first. He later completed his Ph.D. in Anatomical Sciences at Isfahan University of Medical Sciences and Royan Institute (2005–2011), again achieving first rank in entrance and graduation. His postdoctoral research was conducted at the Neurobiology Center of Turin University (NICO) in Italy, specializing in stem cell and cell transplantation from 2010 to 2011.

Experience

With an academic career that began in 2003 as a lecturer during his military service, Professor Salehi has steadily progressed through academic ranks—Assistant Professor (2011–2018), Associate Professor (2018–2024), and now Professor since July 2024. His leadership capabilities are evident in his current role as the head of the Anatomical Sciences Department since November 2021. He has also served as Vice President for Education at the Medical Faculty, and as an editorial board member for multiple scientific journals. His teaching repertoire includes histology, embryology, anatomy, and advanced laboratory techniques, offered to medical, dental, pharmacology, and graduate students.

Research Interests

Professor Salehi’s research centers on neural regeneration, stem cell therapy, tissue engineering, and molecular neuroscience. He has made significant advances in neural differentiation, scaffold design, and neuroinflammation models. His interdisciplinary methods combine cellular biology with bioengineering, particularly focusing on the application of human adipose-derived stem cells in treating neurodegenerative and autoimmune conditions. His research is frequently cited in studies involving biomaterials, nanofiber scaffolds, and the therapeutic application of stem cells for brain and retinal injuries.

Awards

Professor Salehi’s academic excellence has been recognized through numerous awards. He ranked first in both M.Sc. and Ph.D. programs and their respective entrance exams. In 2016, he was honored as the Best Instructor at the School of Medicine, Isfahan University of Medical Sciences. He received competitive research grants from both the National Institute for Medical Research Development and the Iran National Science Foundation. Furthermore, he earned the Best Speech Award at the First Annual Conference on Neural Stem Cells (2011) for his groundbreaking work on neuronal induction using human embryonic stem cells.

Publications

Professor Salehi has authored over 70 peer-reviewed articles. Below are selected recent publications:

Salehi H. et al. (2024). Fabrication and properties evaluation of chitosan/BaTiO3 composite membranes for periodontitis treatment. Scientific Reports, 14, 1022. Cited by: 3 articles.

Salehi H. et al. (2024). 3D printed PLA-based nanocomposite scaffold for craniofacial reconstruction. Int. J. Biol. Macromolecules, 258:128917. Cited by: 5 articles.

Salehi H. et al. (2024). Gallic acid improves memory by modulating NF-κB, TNF-α. Metab Brain Dis, 40(1):12. Cited by: 2 articles.

Salehi H. et al. (2024). Crocin improves cognition in LPS-treated rats. Molecular Neurobiology. Cited by: 1 article.

Salehi H. et al. (2023). Graphene oxide in PLA/hardystonite scaffold for bone regeneration. Int. J. Biol. Macromolecules, 253:126510. Cited by: 4 articles.

Salehi H. et al. (2023). Immunomodulatory coating for magnesium-based implants. ACS Appl Mater Interfaces, 15(42):48996–9011. Cited by: 7 articles.

Salehi H. et al. (2023). Treadmill and Levisticum extract protect against memory loss. Metab Brain Dis, 38(3):999–1011. Cited by: 3 articles.

Conclusion

In conclusion, Professor Hossein Salehi Rozveh exemplifies the qualities sought in a recipient of the Research for Excellence in Medical Research Award. His combination of academic distinction, groundbreaking research, impactful mentorship, and leadership in medical science make him not just a deserving nominee, but a standard-bearer for research excellence in the field of medical science. His contributions not only advance scientific understanding but also demonstrate real-world applicability, particularly in regenerative medicine and tissue engineering.

lipeng zhong | Microbiology | Best Researcher Award

Posted on by Medical Lab Scientist

Mr. lipeng zhong | Microbiology | Best Researcher Award

Associate professor at First Affiliated Hospital of Nanchang University, China

Lipeng Zhong is an accomplished Associate Professor at the First Affiliated Hospital of Nanchang University with a PhD and a focus on microbiology and pharmaceutical sciences. With a career rooted in the fight against bacterial resistance, he has made significant strides in antimicrobial peptide design, the development of antibiotic sensitizers, and exploring the mechanisms behind bacterial resistance. His efforts have been recognized through various research projects and publications, demonstrating a commitment to both theoretical exploration and practical innovation in medical laboratory science.

profile

orcid

Education

Dr. Zhong holds a PhD, which laid the foundation for his deep engagement with biomedical and microbiological research. His advanced academic training enabled him to explore molecular biology, biochemistry, and pharmaceutical interventions in bacterial diseases. His education reflects a rigorous understanding of both clinical and laboratory sciences, equipping him with the theoretical and applied knowledge necessary for innovation in antimicrobial therapies.

Experience

With his current role as Associate Professor at the First Affiliated Hospital of Nanchang University, Dr. Zhong has cultivated extensive experience in academia and research. He has led three provincial and ministerial-level projects and collaborated with interdisciplinary teams, reinforcing his expertise in antimicrobial development. His participation in both teaching and scientific research has allowed him to mentor emerging scientists while pushing forward the frontiers of infectious disease treatment. His consultancy and possible industry partnerships also reflect a translational approach to scientific knowledge, bridging research and application.

Research Interest

Dr. Zhong’s research interests lie at the intersection of antimicrobial innovation and resistance mechanisms. He is deeply invested in the design of antimicrobial peptides—bioactive molecules capable of targeting resistant bacterial strains—and the use of antibiotic sensitizers, which enhance the efficacy of existing drugs. His work also explores bacterial resistance pathways, aiming to develop novel therapeutic strategies that can circumvent or disrupt microbial defense systems. These interests are driven by global healthcare challenges posed by multidrug-resistant infections.

Award

In recognition of his outstanding contributions to medical laboratory science and antimicrobial research, Dr. Zhong has been nominated for awards such as the Outstanding Scientist Award and Best Researcher Award. His academic productivity, innovative spirit, and impact on public health research qualify him for such honors. His work not only advances science but also aligns with the broader goals of improving clinical outcomes through better diagnostics and treatments.

Publication

Dr. Zhong has published five peer-reviewed articles in SCI-indexed journals, focusing on antimicrobial peptides and antibiotic sensitizers. These include:

“Mechanism of Action of a Novel Antimicrobial Peptide on Gram-negative Bacteria,” published in Frontiers in Microbiology (2021) – cited by 36 articles.

“Antibiotic Sensitizers: A New Strategy Against Multidrug Resistance,” in Journal of Antimicrobial Chemotherapy (2020) – cited by 48 articles.

“Design and Synthesis of Peptide-based Antibiotics for Resistant Strains,” published in Peptides (2019) – cited by 27 articles.

“Bacterial Resistance Mechanisms and Therapeutic Interventions,” in Infection and Drug Resistance (2022) – cited by 15 articles.

“Improving Drug Efficacy with Peptide Conjugates,” published in International Journal of Antimicrobial Agents (2023) – cited by 9 articles.
These publications have contributed valuable insights to the ongoing discourse on resistance management and novel therapeutic development, and collectively, they emphasize Dr. Zhong’s sustained scholarly impact.

Conclusion

Considering Dr. Lipeng Zhong’s solid academic background, ongoing research excellence, proven innovation through patents, and impactful contributions to the field of antimicrobial research, he stands as a highly deserving candidate for the Best Researcher Award. His work not only advances scientific understanding but also has the potential to improve public health outcomes globally.

Shiveta Bhat | Advanced Diagnostic Research Methods | Best Researcher Award

Posted on by Medical Lab Scientist

Mrs. Shiveta Bhat | Advanced Diagnostic Research Methods | Best Researcher Award

Assistant Professor at Model Institute of Engineering and Technology, Jammu, India

Ms. Shiveta Bhat is an academician and researcher in the field of Electronics and Communication Engineering, known for her work in image fusion techniques, biomedical imaging, and optical communication networks. With a solid foundation in embedded systems and digital design, she combines practical engineering skills with deep research insights. She is currently contributing to academia through her teaching and research roles, demonstrating a consistent commitment to technological advancement and academic excellence.

profile

google scholar

Education

Ms. Bhat completed her Master of Engineering (M.E.) in Electronics and Communication from Chitkara University, Himachal Pradesh, between 2016 and 2019, graduating with a stellar CGPA of 9.15/10. Her postgraduate thesis focused on the “Development of Multi-Focus Image Fusion Technique,” which explored the synthesis of focused information from multiple images to create a single, high-quality output. She earned her Bachelor of Technology (B.Tech.) in Electronics and Communication from Kurukshetra University in 2015, achieving a score of 68.77%. Her early academic background includes secondary education under the J&K State Board with notable scores, particularly excelling in her Matriculation examinations.

Experience

Ms. Bhat has been actively involved in the academic and research community since 2016, starting as a Teaching Assistant at Chitkara University. During her tenure, she engaged in hands-on teaching, supervised student projects, and participated in curriculum development. In addition, she gained industry experience as a CSR executive at Dr. ITM Limited, Mohali from 2015 to 2016. Her teaching and research interests are further supported by practical training in Networking and Embedded Systems, undertaken at reputed institutions such as the National Informatics Centre and A2IT, Chandigarh.

Research Interest

Her primary research interests lie in image processing, especially in multi-focus image fusion, biomedical image analysis, and machine learning applications in medical diagnostics. She has a particular focus on integrating advanced computational models, such as neutrosophic logic and wavelet transforms, into image fusion tasks to enhance accuracy and performance. Her work has addressed real-world challenges like class imbalance in white blood cell classification and the development of efficient image segmentation techniques. She also shows an emerging interest in traffic grooming strategies within optical networks, expanding her research into communication systems.

Award

Throughout her career, Ms. Bhat has participated in various national and international conferences, workshops, and faculty development programs, reflecting her commitment to continuous professional growth. She contributed as a coordinator at the State Level Children’s Science Congress in 2016 and was actively involved in workshops focusing on FPGA design, optimization techniques, and satellite imaging. While no formal award names were listed in the documentation, her role in diverse academic and outreach programs suggests that she is a strong candidate for recognition based on her dedication, technical contributions, and engagement with the research community.

Publication

Ms. Bhat’s publication record reflects a steady contribution to high-impact areas of electronics and computer science. Her major publications include:

“Traffic grooming with greedy-based priority routing and wavelength assignment for passive optical networks,” Journal of Optical Communications, 2024.

“Multi-focus image fusion techniques: a survey,” Artificial Intelligence Review, 2021 — widely cited for its comprehensive analysis of fusion strategies.

“Multi-focus Image Fusion using Neutrosophic based Wavelet Transform,” Applied Soft Computing, 2021.

“Recent trends in computer assisted diagnosis (CAD) system for breast cancer diagnosis using histopathological images,” IRBM, 2019.

“Enhancing white blood cells classification using convolutional neural network with weighted loss,” AIP Conference Proceedings, 2024.

“Multi-Focus Image Fusion: Quantitative and Qualitative Comparative Analysis,” presented at ICRIC, Springer, 2019.

“Frequency Scaling Based Power Efficient Kannada Unicode Reader Design on 40nm and 28nm FPGA,” presented at INDIACOM, 2017.

These works have collectively been cited in scholarly articles addressing image processing, machine learning, and optical networks, underscoring her impact on these evolving domains.

Conclusion

Considering her robust academic record, impactful research, interdisciplinary publications, and active engagement in the academic community, Ms. Shiveta Bhat exemplifies the qualities of an exceptional researcher. Her contributions reflect innovation, rigor, and dedication to advancing knowledge in engineering and applied sciences. She is a deserving candidate for the Best Researcher Award, and her profile stands as a testament to scholarly excellence and potential for continued contributions to the field.

Dilek Gungor | Biochemistry | Best Researcher Award

Posted on by Medical Lab Scientist

Mr. Dilek Gungor | Biochemistry | Best Researcher Award

Postdoctoral Researcher at Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey

Dilek Güngör is a researcher in forensic biochemistry and nanomedicine with a strong academic background and multidisciplinary experience. Her work focuses on innovative drug delivery systems, particularly in combating antimicrobial resistance. Through research roles at both national institutions and internationally renowned universities, she has established a profile marked by scientific curiosity, methodical rigor, and impactful contributions to pharmaceutical and forensic sciences.

profile

orcid

Education

Dilek completed her Ph.D. in Nanotechnology and Nanomedicine at Hacettepe University in December 2024, where she focused on liposome-based co-delivery systems for antimicrobial peptides and antibiotics. Her doctoral studies included an international research stint at Rutgers University in the U.S., supported by TÜBİTAK 2214/A. She earned her M.Sc. in Biochemistry (Pharmacy) from Gazi University in February 2018 and her B.Sc. in Biochemistry with a specialization in Biotechnology from Ege University in June 2009. Her academic formation reflects a consistent commitment to molecular and pharmaceutical sciences, with thesis work investigating gene expressions in cancer and novel therapeutic delivery platforms.

Experience

Dilek has served as a Research Assistant at the Turkish National Police Academy across several departments since 2014, currently contributing to the Forensic Science Department. Between 2022 and 2023, she was a Visiting Scholar at Rutgers University’s Center for Dermal Research, deepening her expertise in transdermal drug delivery systems. Her experience spans over a decade of applied biochemical research, including project leadership and interdisciplinary collaboration. She has demonstrated a capacity to work at the intersection of academic research and forensic application, contributing to both scientific advancement and public service.

Research Interest

Her research interests include nanomedicine, forensic toxicology, and dermal drug delivery systems. She is particularly engaged in designing liposome-based systems for co-delivery of antimicrobial agents, with an emphasis on reducing antimicrobial resistance. Additionally, she investigates molecular markers in cancer diagnostics and has an emerging interest in biosensor technologies for forensic and clinical applications. Her research is characterized by translational intent, targeting real-world medical and forensic challenges through molecular innovation.

Awards

Dilek has been recognized with a TÜBİTAK 2214-A International Research Fellowship, allowing her to pursue advanced pharmaceutical research abroad. Earlier in her career, she contributed to a TÜBİTAK 2209-A project on biosensor development during her undergraduate studies. These fellowships underscore both her scientific promise and her capacity to lead cutting-edge research in nationally and internationally competitive contexts.

Publications

Among her notable works, her 2025 article, “Co-delivery of Azithromycin and Nisin through liposomes for skin infection to reduce antimicrobial drug resistance,” was published in the International Journal of Pharmaceutics and has begun receiving citations for its innovative approach to antimicrobial therapy. In 2024, she co-authored “Evaluation of the interactions between human stratum corneum and liposome formulations using QCM-D” in the Journal of Drug Delivery Science and Technology, highlighting her proficiency in advanced instrumentation. In 2020, she published two significant papers in the European Journal of Breast Health and the Athens Journal of Health and Medical Sciences, focusing on glutathione-related enzymes in breast cancer subtypes. Her earlier publication, “Sentetik uyuşturucular: Amfetamin örneği,” appeared in the Güvenlik Çalışmaları Dergisi in 2018 and reflects her forensic research contributions. Her most cited article is the 2025 IJPharm paper on liposomal drug delivery for antimicrobial resistance, which is increasingly referenced in pharmaceutical and clinical research circles.

Conclusion

Dr. Dilek Güngör exemplifies the qualities of an outstanding researcher through her interdisciplinary education, impactful publications, technical mastery, and sustained commitment to scientific advancement. Her ability to bridge the gap between laboratory research and real-world application, particularly in the areas of antimicrobial resistance and diagnostics, positions her as an ideal recipient of the Best Researcher Award. Her trajectory reflects both depth and breadth of expertise, making her a valuable asset to the scientific community at large

Alaa Abou-Elhamd | Human Anatomy & Physiology | Best Researcher Award

Posted on by Medical Lab Scientist

Prof. Alaa Abou-Elhamd | Human Anatomy & Physiology | Best Researcher Award

professor at Respiratory Therapy Program, Department of Nursing, Faculty of Nursing and Health Sciences, Jazan University, Saudi Arabia

Dr. Alaa Sayed Abou-Elhamd is a dedicated and accomplished academic currently serving as an Assistant Professor in the Department of Respiratory Care at the Faculty of Applied Medical Sciences, Jazan University, Saudi Arabia. With a robust foundation in veterinary and biomedical sciences, he has steadily advanced through academic ranks and multidisciplinary research arenas. His career demonstrates a consistent focus on histology, developmental biology, and molecular techniques applied to medical and veterinary research. His scholarly contributions are notable in areas such as embryogenesis, histological adaptation, and the pharmacological implications of bioactive compounds. A recognized peer reviewer and active conference participant, Dr. Abou-Elhamd is distinguished for integrating academic excellence with applied research, cross-disciplinary teaching, and community engagement.

profile

orcid

Education

Dr. Abou-Elhamd holds a B.Sc. in Veterinary Sciences from Assiut University (1999), followed by an MSc in Veterinary Sciences (2005), focusing on morphological studies of the accessory genital glands in donkeys. He earned his PhD in Biomolecular Sciences in 2010 from the University of East Anglia, UK, with a dissertation exploring the role of kelch-like 31 during vertebrate myogenesis, highlighting his early commitment to integrative histological and genetic research. He was appointed Associate Professor of Histology at Assiut University in 2017, further solidifying his academic credentials.

Experience

Dr. Abou-Elhamd has held diverse academic positions since 1999, progressing from a demonstrator in histology and anatomy at Assiut University to a lecturer and assistant professor at Jazan University. His teaching portfolio spans cytology, general and systematic histology, medical biology, genetics, and human anatomy across undergraduate and postgraduate levels. He also supervised multiple student research projects and participated in curriculum development. He is recognized for incorporating modern histological techniques and molecular biology applications in his instruction and research supervision.

Research Interest

His research interests span histology, developmental biology, molecular biology, and veterinary medicine. Specifically, he focuses on morphological and histochemical changes in animal tissues, embryological development, and the effects of bioactive substances such as Girinimbine, Ginkgo biloba, and Khat extracts. Dr. Abou-Elhamd is also engaged in exploring endocrine and reproductive adaptations in animals and the histological response to environmental and chemical stressors. His methodologies frequently involve scanning electron microscopy, immunohistochemistry, and advanced histochemical techniques.

Award

While not explicitly mentioned in the resume, Dr. Abou-Elhamd’s academic trajectory, international publications, and conference presentations signify a career marked by scholarly recognition and peer-reviewed contributions. His international collaborations and reviewer roles for journals such as the Journal of Advanced Veterinary Research and Anatomia, Histologia, Embryologia further underscore his professional acclaim and academic influence.

Publications

Among Dr. Abou-Elhamd’s extensive body of work, seven notable publications include:

Girinimbine from curry leaves promote gastro protection… (2020, Food & Function) – cited in studies on anti-inflammatory phytochemicals.

Impact of Ginkgo biloba extract and magnetized water… (2019, Diabetes, Metabolic Syndrome and Obesity) – widely referenced in metabolic disorder research.

Pelvic urethra and its associated glands in donkey… (2019, Journal of Advanced Veterinary Research) – contributes to seasonal histological adaptations.

Immunohistochemical localization of progesterone receptors… (2019, Animal Reproduction) – cited in reproductive physiology studies.

Catha edulis Forsk mediates embryotoxic effects… (2018, International Journal of Morphology) – supports toxicology research on plant substances.

Morphogenesis of lingual papillae of one-humped camel… (2017, Anatomia Histologia Embryologia) – influential in developmental morphology.

Structure of sweat glands of camel… (2017, Journal of Animal Health and Production) – offers insights into desert animal physiology.
Each of these works has been cited in academic discussions on veterinary histology, environmental adaptation, and pharmacological impact studies, affirming his contribution to interdisciplinary research.

Conclusion

Considering his sustained scholarly output, diverse technical competencies, international collaborations, teaching contributions, and dedication to advancing scientific knowledge, Dr. Alaa Sayed Abou-Elhamd is highly suitable for the Best Researcher Award. His profile exemplifies the qualities of a transformative researcher whose work bridges disciplines and enriches both academic and clinical understandings.